3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Mesothelioma, Malignant
1
Malignant Solid Tumour
1
Colorectal Cancer Metastatic
1
Carcinoma, Small Cell
1
Interventions
Topotecan
3
pembrolizumab
2
Gemcitabine
2
vinflunine
1
bemiparin
1
belotecan
1
apalutamide
1
Temozolomide
1
Taxes
1
Sorafenib
1
Penfluridol
1
Pemetrexed
1
Paclitaxel
1
Nortriptyline
1
Nivolumab
1
Ipilimumab
1
Etoposide
1
Docetaxel
1
Cisplatin
1
Carboplatin
1
Arsenic Trioxide
1
ARQ 197
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Small Cell
×
ARQ 197
×
Clear all
NCT02608411
2023-10-13
TIMES
Istituto Oncologico Veneto IRCCS
Phase 2
Terminated
5 enrolled